Irish Journal of Medical Science

, Volume 163, Issue 11, pp 503–504

Hepatitis C updated

  • M. J. Whelton
  • J. Power
  • E. Kenny-Walsh


  1. 1.
    Purcell, R. H., Miller, R. H. The nature of genetic variation among viruses, J. Hepatol. 1991; 13 (Suppl. 4): S2-S5.Google Scholar
  2. 2.
    Dienhardt, F. Human viral hepatitis; Hypothesis to fact, in Viral Hepatitis and Liver Disease, Eds. Hollinger F. B., Lemmon S. M., Margolis H. S. Williams and Wilkins, Baltimore, Page 5–11.Google Scholar
  3. 3.
    Krugman, S., Giles, J. P., Hammond, J. Infectious hepatitis; evidence for two distinctive clinical, epidemiological and immunological types of infection. J. Amer. Med. Assn. 1967; 200: 365–373.CrossRefGoogle Scholar
  4. 4.
    Esteban, R., Epidemiology of hepatitis C virus infection, J. Hepatology, 1993; 17 (Suppl. 3): S67-S71.Google Scholar
  5. 5.
    Schiff, E. R. Hepatitis C among health care providers: Risk factors and possible prophylaxis. Gastroenterology 1992; 16: 1300–1301.Google Scholar
  6. 6.
    Ohto, H., Terazawa, S Sasaki, N. et al. Transmission of Hepatitis C virus from mothers to infants, New Engl. J. Med. 1994; 330: 744–50.Google Scholar
  7. 7.
    Scheuer, P. J., Ashrafzadeh, P., Sherlock, S., Brown, D., Dusheiko, G. M. The pathology of hepatitis C. Hepatology 1992; 15: 567–571.PubMedCrossRefGoogle Scholar
  8. 8.
    Hoofnagle, J. H., Mullen, K. D., Jones, D. B. et al. Treatment of Chronic Non-A, Non-B Hepatitis with recombinant humanalpha interferon; a preliminary report. N. Eng. J. Med: 1987; 315: 1575–8.CrossRefGoogle Scholar
  9. 9.
    Hoofnagle, J. H., Bisceglie, A. M., Shindo, M. J. Antiviral therapy ofhepatitis C-present and future. Hepatology 1993; 17 (Suppl. 3): SI 30-S136.Google Scholar
  10. 10.
    Simmonds, P., Holmes, E.C., Cha, T-A, etal. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. J. Gen. Virol. 1993; 74: 2391–99.PubMedCrossRefGoogle Scholar
  11. 11.
    Van Thiel, D. H., Friedlander, L., Fagiuoli, S., Wright, H. I., Irish, W., Gavaler, J. S. Response to interferon alpha therapy is influenced by the iron content of the liver. J. Hepatology 1994; 20: 410–415.CrossRefGoogle Scholar
  12. 12.
    Misiani, R., Bellavita, P., Fenili, D. et al. Interferon Alpha-2a therapy in cryoglobulinemia associated with Hepatitis C virus. N. Engl. J. Med. 1994; 330: 751–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Fargion, S., Piperno, A., Cappellini, M. D. et al. Hepatitis C. virus and Porphyria Cutanea Tarda: evidence of a strong association. Hepatology 1992; 16: 1322–1326.Google Scholar
  14. 14.
    Prozter, U., Ochsendorf, F. R., Ochsendorf, A. L., Holtermuller, K. H. Exacerbation of lichen planus during interferon alpha-2a therapy for chronic hepatitis C. Gastroenterology 1993; 104: 903–905.Google Scholar
  15. 15.
    Johnson, R. J., Gretch, D. R., Yamabe, H. et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N. Engl. J. Med. 1993; 328: 465–70.PubMedCrossRefGoogle Scholar
  16. 16.
    Wilson, S. E., Lee, W. M., Murakami, C. et al. Mooren’s corneal ulcers and hepatitis C virus infection. N. Engl. J. Med. 1993; 329: 62.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 1994

Authors and Affiliations

  • M. J. Whelton
    • 1
  • J. Power
    • 2
  • E. Kenny-Walsh
    • 1
  1. 1.Departments of Gastroenterology & HepatologyRegional HospitalCork
  2. 2.Blood Transfusion BoardMunster BranchCork

Personalised recommendations